IKBKE Knockout Cell Line - CD BioSciences

service-banner

IKBKE Knockout Cell Line

IKBKE Knockout Cell Line

SPL-01700

Size Price
1 Unit Online Inquiry
Description
2bp insertion
Target Information
Target Name IKKε
Gene Abbr. IKBKE
Gene ID 9641
Full Name inhibitor of nuclear factor kappa B kinase subunit epsilon
Alias IKK-E, IKK-i, IKKE, IKKI
Species Human
Genomic Locus chr1:206476237
Transcript NM_014002
WT Expression Level 3.84 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing)
Introduction IKBKE is a noncanonical I-kappa-B (see MIM 164008) kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer (MIM 114480) oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines (Hutti et al., 2009 [PubMed 19481526]).[supplied by OMIM, Oct 2009].
Product Details
Cell Line Model HAP1
Genotype HAP1 cell line, edited by CRISPR/Cas to contain a 2bp insertion in a coding exon of IKBKE.
Description 2bp insertion
Parental Cell Line C631
Guide RNA Sequence ACGAGGCGCATGATGTTCCC
PCR Primer Forward: GAGAATCCAGATGGTACCTCCATAC
Reverse: AGGTACTCCTCAGTCCCATAGAC
Handling Specifications
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish.
Culture Medium IMDM + 10% FCS
Growth Properties Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20.
Freeze Medium IMDM + 20% FCS + 10% DMSO
Biosafety Level BSL-1
Disclaimer This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.